2 not yet recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 2 |
Follow Zeprumetostat Tablets: new trials by email Literature Review of Zeprumetostat Tablets trials Research Report on Zeprumetostat Tablets
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Prospective Clinical Study of Zeprumetosta in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma Zeprumetostat Tablets - Cutaneous T-Cell Lymphoma/Mycosis Fungoides/Sézary Syndrome | Phase 2 | Not yet recruiting | Peking University First Hospital | 33 | 2026-10-31 | 2026-10-02 |
| Retlirafusp Alfa Combined With Zeprumetostat, Apatinib, and Chemotherapy as First-Line Treatment for Metastatic GC/GEJC Retlirafusp alfa, zeprumetostat, apatinib - Gastric Cancer/Gastroesophageal Junction Adenocarcinoma | Phase 2 | Not yet recruiting | Fudan University | 55 | 2026-10-01 | 2026-10-14 |
Lymphoma, T-Cell, Cutaneous (1) · Stomach Neoplasms (1)
Fudan University (1) · Peking University First Hospital (1)
China (1)